Researchers find new drugs to fight MAC.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D017291:Clarithromycin / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D017828:Rifabutin / Q000627:therapeutic use; D012293:Rifampin / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use
D000995:Antitubercular Agents; D010919:Placebos; D017828:Rifabutin; D017291:Clarithromycin; D012293:Rifampin; C018421:rifapentine